Novartis Cosentyx® gains positive CHMP opinion for pediatric psoriasis, reinforcing established efficacy and safety profile

    NEXT STORY
    Orion publishes Half-Year Financial Report for January-June 2020 on Friday 17 July 2020
    PREV STORY
    Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    3D Signatures Reports First Quarter Financial Results for Fiscal 2018

    TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the ...

    author_avatar
    NASDAQ Market News

    ZIOPHARM Oncology Reports First Quarter 2017 Financial Results and Provides Update on Recent Activities

    – Advancing Plans to Initiate Pivotal Study for Ad-RTS-hIL-12 + Veledimex for Treatment of Recurrent ...

    author_avatar
    NASDAQ Market News

    Agios to Present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020

    author_avatar
    NASDAQ Market News